Clinical trial

BAROSTIM THERAPY™ in Heart Failure With Reduced Ejection Fraction

NCT02880618

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2016-12-13

PhaseN/A

Study timeline

Study start (actual)2016-12-13Date precision: day

Registry last updated2026-09-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failureunresolved

Interventions

Barostim Neo™ SystemDEVICE

Sponsors & collaborators

CVRx, Inc.lead sponsor

Mapped research locations

DresdenGermany3 BerlinGermany2 LeipzigGermany2 HamburgGermany1 HanoverGermany1 CologneGermany1 FrankfurtGermany1 MainzGermany1 MünsterGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02880618 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.